Blood pressure medication recalled nationwide: FDA
Key Points:
- Inventia Healthcare Limited of India is voluntarily recalling over 11,000 bottles of Chlorthalidone blood pressure medication due to failed dissolution testing.
- The recall affects 100 and 1,000 tablet bottles sold nationwide, as the medication did not meet FDA dissolution specifications.
- Dissolution testing ensures a drug properly dissolves and releases active ingredients, which is crucial for consistent drug performance and quality.
- Chlorthalidone is a diuretic used to treat high blood pressure and reduce swelling caused by heart, kidney, or liver disease.
- The medication was distributed in the U.S. by Rising Pharma Holdings, Inc., based in East Brunswick, New Jersey.